Description
The test detects IgM antibodies against the core antigen of the Hepatitis B virus (HBV). It is primarily used to diagnose acute or recent Hepatitis B infection, as IgM antibodies typically appear during the early phase of infection. The HBCM test is ordered based on symptoms, including jaundice, fatigue, nausea and abdominal pain. A positive result indicates a recent HBV infection or reactivation. This test is crucial for early detection, monitoring disease progression and guiding treatment decisions for Hepatitis B.
Reviews
There are no reviews yet.